Merck

+$0.81 (+0.86%) Today

+$0.11 (+0.12%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.

About MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

Employees

68,000

Headquarters

Kenilworth, New Jersey

Founded

1891

MRK Key Statistics

Market cap

Price-Earnings ratio

16.79

Dividend yield

2.86

Average volume

12.61M

High today

$94.79

Low today

$93.57

Open price

$94.25

Volume

9.02M

52 Week high

$94.92

52 Week low

$70.89

MRK News

MarketWatch16h

Merck Gets EU Approval of Expanded Keytruda Use in Breast Cancer - MarketWatch

By Colin Kellaher Merck & Co. on Tuesday said the European Commission approved the expanded use of its blockbuster cancer drug Keytruda for certain breast-canc

Simply Wall StMay 21

Merck stock performs better than its underlying earnings growth over last five years

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you'd generally like to see the share price r

BenzingaMay 20

CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting

European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE: MRK) Keytrud

Analyst ratings

Buy

57.7%

Hold

42.3%

Sell

MRK Earnings

$0.00

$0.71

$1.43

$2.14

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Available Jul 28, Pre-Market

More MRK News

MarketWatchMay 20

Merck Gets CHMP Backing for Expanded Keytruda Use in Melanoma >MRK - MarketWatch

By Colin Kellaher Merck & Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of it